佐賀大学 · 医療系

研究キーワードchronic myeloid leukemia・tyrosine kinase inhibitors・T-cell repertoire・double-hit lymphoma・epcoritamab・generic imatinib

ここは公開データのプレビューです。個別の適合理由、連絡角度、保存機能はログイン後に利用できます。

• Clinical Features and T-Cell Repertoire of Chronic Myeloid Leukemia Patients Who Attempt Discontinuation of Tyrosine Kinase Inhibitors: The ISAC-TFR Study.2025 · Cancer medicine
• Orally available decitabine prodrug OR-2100 induces mitotic perturbation for the treatment of double-hit lymphoma2025 · Blood Neoplasia
• Simulation of perioperative Ibrutinib withdrawal using a population pharmacokinetic model and sparse clinical concentration data.2025 · Cancer chemotherapy and pharmacology
• Treating Hematological Malignancies With OR-2100, an Orally Bioavailable Prodrug of Decitabine.2025 · Cancer science

• 公式プロフィール